AstraZeneca PLC

AZN

GB0009895292

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Employees

89,900

Sector

Pharmaceuticals

Calendar

11:56am - IASLC World Lung Cancer Conference - Abstract No #PL02.07

Related indices

STOXX Europe 600 Index (EUR) , FTSE 100

More about the company

Income Statement and Estimates

More financial data

Analysis / Opinion

ASTRAZENECA : Healthy operational momentum sustained in Q2

July 26, 2024 at 12:10 pm EDT

'Another Good Year' Ahead for AstraZeneca: CEO Pascal Soriot

February 09, 2023 at 10:04 am EST

More Strategies

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

166.36USD

Average target price

183.81USD

Spread / Average Target

+10.49%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Market Closed - London S.E. Other stock markets 11:35:09 2024-09-06 am EDT			5-day change	1st Jan Change
12,650.00 ^GBX	+0.88%		-4.70%	+19.34%

Sep. 06	Veeva Systems: leader in cloud solutions for the life sciences industry
Sep. 05	Health Care Declines as Risk Aversion Weighs - Health Care Roundup	DJ

Veeva Systems: leader in cloud solutions for the life sciences industry	Sep. 06
Health Care Declines as Risk Aversion Weighs - Health Care Roundup	Sep. 05	DJ
Sector Update: Health Care Stocks Fall Late Afternoon	Sep. 05	MT
Sector Update: Health Care Stocks Slide Thursday Afternoon	Sep. 05	MT
European Equities Close Mostly Lower in Thursday Trading; Eurozone Retail Trade Volume Rises	Sep. 05	MT
Top Midday Stories: Verizon to Acquire Frontier Communications for $20 Billion; Nvidia Says It Hasn't Been Subpoenaed by DOJ	Sep. 05	MT
European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading	Sep. 05	MT
Stocks on the back foot ahead of nonfarm payrolls	Sep. 05	AN
Sector Update: Health Care Stocks Flat to Higher Premarket Thursday	Sep. 05	MT
Sector Update: Health Care	Sep. 05	MT
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Thursday Ahead of Key Jobs Data	Sep. 05	MT
AstraZeneca Employees Detained in China Over Alleged Data, Drug-Import Violations -- Update	Sep. 05	DJ
AstraZeneca's Oncology Division Employees Detained in China in Data, Drug Import Probes	Sep. 05	MT
ASTRAZENECA : Goldman Sachs keeps its Buy rating	Sep. 05	ZD
AstraZeneca Says Aware of China Investigation; Five Oncology Division Employees Reportedly Detained	Sep. 05	MT
China probing AstraZeneca employees for potential illegal acts	Sep. 05	AN
AstraZeneca Employees Detained in China Over Data and Drug-Import Scrutiny	Sep. 05	DJ
UBS raises Sage Group to 'neutral'	Sep. 05	AN
China detains AstraZeneca staff in data, drug-import probes, Bloomberg News reports	Sep. 05	RE
ASTRAZENECA : Gets a Buy rating from Berenberg	Sep. 03	ZD
US will still pay at least twice as much after negotiating drug prices	Sep. 03	RE
AstraZeneca: to present its advances in oncology	Sep. 03	CF
Qiagen Expands Companion Diagnostics Collaboration with AstraZeneca	Aug. 29	MT
Qiagen Expands Master Collaboration Agreement with AstraZeneca	Aug. 28	MT
AlphaValue/Baader Europe Downgrades AstraZeneca to Reduce, Trims PT	Aug. 28	MT

AstraZeneca PLC

Equities

AZN